Downregulation of ITGA5 inhibits lymphangiogenesis and cell migration and invasion in male laryngeal squamous cell carcinoma

[1]  H. Deng,et al.  ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma , 2022, Journal of clinical laboratory analysis.

[2]  Meiwan Chen,et al.  Sequential Release of Pooled siRNAs and Paclitaxel by Aptamer-Functionalized Shell-Core Nanoparticles to Overcome Paclitaxel Resistance of Prostate Cancer. , 2021, ACS applied materials & interfaces.

[3]  K. Pantel,et al.  Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions , 2021, Oncogene.

[4]  Di Wu,et al.  Dysregulated YY1/PRMT5 axis promotes the progression and metastasis of laryngeal cancer by targeting Hippo pathway , 2020, Journal of Cellular and Molecular Medicine.

[5]  H. Ford,et al.  VEGF-C Mediates Tumor Growth and Metastasis Through Promoting EMT- Epithelial Breast Cancer cell Crosstalk , 2020, Oncogene.

[6]  Di Wu,et al.  PRMT5/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma , 2020, Cell Death & Disease.

[7]  Hui-Hua Li,et al.  Angiotensin II Stimulates the Proliferation and Migration of Lymphatic Endothelial Cells Through Angiotensin Type 1 Receptors , 2020, Frontiers in Physiology.

[8]  Gang Wang,et al.  ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors , 2020, BMC cancer.

[9]  T. Qiao,et al.  Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms , 2020, Frontiers in Oncology.

[10]  K. Alitalo,et al.  VEGF-C Protects the Integrity of Bone Marrow Perivascular Niche. , 2020, Blood.

[11]  I. Talaat,et al.  Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms , 2020, International journal of molecular sciences.

[12]  M. Hsu,et al.  WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade , 2019, Front. Oncol..

[13]  H. Qin,et al.  Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker , 2019, Molecular oncology.

[14]  X. Fang,et al.  O-GlcNAcylation of ITGA5 facilitates the occurrence and development of colorectal cancer. , 2019, Experimental cell research.

[15]  Yan Wang,et al.  Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway. , 2019, Archives of oral biology.

[16]  K. Alitalo,et al.  uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis , 2018, Nature Communications.

[17]  Wenqi Wang,et al.  LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling. , 2018, Molecular cell.

[18]  Jincai Luo,et al.  Heterogeneity of tumor lymphangiogenesis: Progress and prospects , 2018, Cancer science.

[19]  Q. Zhan,et al.  The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment , 2018, Molecular Cancer.

[20]  M. Detmar,et al.  Multiple roles of lymphatic vessels in tumor progression. , 2018, Current opinion in immunology.

[21]  T. Zhou,et al.  Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion , 2018, Gastric Cancer.

[22]  T. Simoncini,et al.  Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[23]  M. Detmar,et al.  Tumor lymphangiogenesis and new drug development. , 2016, Advanced drug delivery reviews.

[24]  Baoquan Liu,et al.  Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF‐C in Human Colon Cancer , 2016, Anatomical record.

[25]  N. Gammoh,et al.  MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin , 2014, Oncotarget.

[26]  Shu Wu,et al.  TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma , 2014, Gut.

[27]  Mina J. Bissell,et al.  The perivascular niche regulates breast tumor dormancy , 2013, Nature Cell Biology.

[28]  J. Alexander,et al.  Integrins and Their Extracellular Matrix Ligands in Lymphangiogenesis and Lymph Node Metastasis , 2012, International journal of cell biology.

[29]  Q. Paulson,et al.  Alcohol promotes breast cancer cell invasion by regulating the Nm23-ITGA5 pathway , 2011, Journal of experimental & clinical cancer research : CR.

[30]  S. Hirakawa From tumor lymphangiogenesis to lymphvascular niche , 2009, Cancer science.

[31]  D. McDonald,et al.  alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation. , 2009, The American journal of pathology.

[32]  B. Garmy-Susini,et al.  Integrins in angiogenesis and lymphangiogenesis , 2008, Nature Reviews Cancer.

[33]  Zhuang Wu,et al.  Tumor lymphangiogenesis and lymphangiogenic growth factors. , 2008, Archives of medical research.

[34]  F. Kruse,et al.  Inhibition of Inflammatory Lymphangiogenesis by Integrin α5 Blockade , 2007 .

[35]  Chang H. Kim The greater chemotactic network for lymphocyte trafficking: chemokines and beyond , 2005, Current opinion in hematology.

[36]  J. Groopman,et al.  Extracellular matrix regulates endothelial functions through interaction of VEGFR‐3 and integrin α5β1 , 2005 .

[37]  Alexander Marks,et al.  Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas , 2002, Modern Pathology.

[38]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[39]  Jinghe Huang,et al.  articleVascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA / ROCK-2 / moesin cascade , 2010 .